首页> 外文期刊>BMC Ophthalmology >Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study
【24h】

Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study

机译:补充因子B rs4151667(L9H)多态性的作用及其与CFH Y402H和C3 RS2230199(R102G)风险变体在年龄相关性黄斑变性中的风险变体:案例对照研究

获取原文
获取外文期刊封面目录资料

摘要

Age-related Macular Degeneration (AMD) is a complex eye disease, which is genetically associated with different susceptibility loci. We planned to investigate the possible association of Complement Factor B (CFB) rs4151667 (L9H) variants and their possible interaction with Complement Factor H (CFH) Y402H and Complement factor 3 (C3) rs2230199 (R102G) in AMD. This case-control association study included 216 advanced type AMD patients and 191 healthy individuals for evaluation. Extracted-DNA samples were genotyped for the polymorphic regions of CFB rs4151667 (L9H), CFH Y402H and C3 rs2230199 (R102G). The distribution of CFB rs4151667 (L9H) genotypes was not significantly different in the AMD patients compared to that of controls (P?=?0.18). The AT genotype frequencies for CFB was non significantly lower in AMD group (6.5% vs. 13.1%, AOR?=?0.49, CI?=?0.23–1.04, P?=?0.064(. The A allele of CFB rs4151667 (L9H) was found to be non-significantly lower in AMD patients. CFB rs4151667 (L9H) had no protective interactional effect against CFH (Y402H) and C3 (R102G) risk variants. This study showed that the protective role of CFB rs4151667 (L9H) in AMD is not significant and it has no significant protective interactional effect against CFH (Y402H) and C3 (R102G) risk variants.
机译:年龄相关的黄斑变性(AMD)是一种复杂的眼部疾病,其遗传与不同的易感位点相关。我们计划研究补体因子B(CFB)RS4151667(L9H)变体的可能缔合及其与补体系数H(CFH)Y402H(CFH)Y402H的相互作用和AMD中的补体系数3(C3)RS2230199(R102G)。这种案例控制协会研究包括216名高级AMD患者和191名健康个体进行评估。提取的-DNA样品是CFB RS4151667(L9H),CFH Y402H和C3 RS2230199(R102G)的多态区的基因分型。与对照组相比,AMD患者的CFB RS4151667(L9H)基因型的分布没有显着差异(P?= 0.18)。 CFB的基因型频率在AMD组中未显着降低(6.5%与13.1%,AOR?= 0.49,CI?=?0.23-1.04,P?= 0.064(。CFB RS4151667的等位基因(L9H )在AMD患者中被发现是非显着降低的。CFB RS4151667(L9H)对CFH(Y402H)和C3(R102G)风险变体没有保护性间作效应。该研究表明CFB RS4151667(L9H)的保护作用AMD不显着,对CFH(Y402H)和C3(R102G)风险变体没有显着的保护性间效果。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号